EXE vs. DNTL, SIA, WELL, DR, KDA, NLH, PHA, BLU, TRIL, and TLRY
Should you be buying Extendicare stock or one of its competitors? The main competitors of Extendicare include dentalcorp (DNTL), Sienna Senior Living (SIA), WELL Health Technologies (WELL), Medical Facilities (DR), KDA Group (KDA), Nova Leap Health (NLH), Premier Health of America (PHA), BELLUS Health (BLU), Trillium Therapeutics (TRIL), and Tilray Brands (TLRY). These companies are all part of the "medical" sector.
dentalcorp (TSE:DNTL) and Extendicare (TSE:EXE) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, community ranking, institutional ownership, earnings, analyst recommendations, valuation and dividends.
Extendicare has a net margin of 2.63% compared to Extendicare's net margin of -4.44%. dentalcorp's return on equity of 37.03% beat Extendicare's return on equity.
Extendicare received 125 more outperform votes than dentalcorp when rated by MarketBeat users. However, 63.41% of users gave dentalcorp an outperform vote while only 48.87% of users gave Extendicare an outperform vote.
51.3% of dentalcorp shares are held by institutional investors. Comparatively, 20.2% of Extendicare shares are held by institutional investors. 0.2% of dentalcorp shares are held by insiders. Comparatively, 13.9% of Extendicare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Extendicare has lower revenue, but higher earnings than dentalcorp. dentalcorp is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.
In the previous week, dentalcorp and dentalcorp both had 1 articles in the media. dentalcorp's average media sentiment score of 1.00 beat Extendicare's score of 0.00 indicating that Extendicare is being referred to more favorably in the news media.
dentalcorp currently has a consensus price target of C$10.03, indicating a potential upside of 43.46%. Extendicare has a consensus price target of C$8.33, indicating a potential upside of 12.16%. Given Extendicare's stronger consensus rating and higher probable upside, equities analysts plainly believe dentalcorp is more favorable than Extendicare.
dentalcorp has a beta of 1.38, indicating that its share price is 38% more volatile than the S&P 500. Comparatively, Extendicare has a beta of 1.23, indicating that its share price is 23% more volatile than the S&P 500.
Summary
Extendicare beats dentalcorp on 9 of the 17 factors compared between the two stocks.
Get Extendicare News Delivered to You Automatically
Sign up to receive the latest news and ratings for EXE and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EXE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Extendicare Competitors List
Related Companies and Tools
